ENTRY       D09900                      Drug
NAME        Eteplirsen (USAN/INN);
            Exondys 51 (TN)
PRODUCT     EXONDYS 51 (Sarepta Therapeutics)
FORMULA     C364H569N177O122P30
EXACT_MASS  10300.589
MOL_WEIGHT  10305.7382
SEQUENCE    cuccaacauc aaggaagaug gcauuucuag
REMARK      ATC code: M09AX06
            Product: D09900<US>
EFFICACY    Translation inhibitor
  DISEASE   Duchenne muscular dystrophy (DMD variant amenable to exon 51 skipping) [DS:H01963]
  TYPE      Antisense oligonucleotide
COMMENT     Treatment of Duchenne muscular dystrophy
TARGET      DMD* [HSA_VAR:1756v1] [HSA:1756] [KO:K10366] (pre-mRNA exon51)
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
               M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
                M09AX Other drugs for disorders of the musculo-skeletal system
                 M09AX06 Eteplirsen
                  D09900  Eteplirsen (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Eteplirsen
               D09900  Eteplirsen (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Cytoskeleton
                DMD* [HSA_VAR:1756v1]
                 D09900  Eteplirsen (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09900
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09900
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D09900
DBLINKS     CAS: 1173755-55-9
            PubChem: 124490612
///
